Antiarrhythmic peptide from venom of spider Grammostola spatulat

Chemistry: analytical and immunological testing – Biospecific ligand binding assay

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530324, 424538, G01N 33566

Patent

active

059688386

ABSTRACT:
The invention provides a novel peptide isolated from the venom of the spider Grammostola spatulata which peptide has antiarrhthymic activity. The invention also provides methods of treating arrhthymia comprising administering to a patient in need of such treatment an effective amount of the peptide. The invention further provides pharmaceutical compositions and methods of mediating hypotonic cell swelling induced calcium increase in cells.

REFERENCES:
patent: 4925664 (1990-05-01), Jackson et al.
patent: 5064657 (1991-11-01), Jackson et al.
patent: 5122596 (1992-06-01), Phillips et al.
patent: 5196204 (1993-03-01), Jackson et al.
patent: 5281693 (1994-01-01), Jackson et al.
Lampe et al., "Isolation and Pharmacological Characterization of .omega.-Grammotoxin SIA, a Novel Peptide Inhibitor of Neuronal Voltage-Sensitive Calcium Channel Responses", Molecular Pharmacology, 44:451-460, May 18, 1993.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antiarrhythmic peptide from venom of spider Grammostola spatulat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiarrhythmic peptide from venom of spider Grammostola spatulat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarrhythmic peptide from venom of spider Grammostola spatulat will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2055000

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.